These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan. Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033 [TBL] [Abstract][Full Text] [Related]
13. Nusinersen for the treatment of spinal muscular atrophy. Chiriboga CA Expert Rev Neurother; 2017 Oct; 17(10):955-962. PubMed ID: 28884620 [TBL] [Abstract][Full Text] [Related]
14. Spinal muscular atrophy in Ghanaian children confirmed by molecular genetic testing: a case series. Hammond CK; Oppong E; Ameyaw E; Dogbe JA Pan Afr Med J; 2023; 46():78. PubMed ID: 38282771 [TBL] [Abstract][Full Text] [Related]
15. [Clinical practice guidelines for spinal muscular atrophy]. Writing Group For Practice Guidelines For Diagnosis And Treatment Of Genetic Diseases Medical Genetics Branch Of Chinese Medical Association ; Pan J; Tan H; Zhou M; Liang D; Wu L Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Mar; 37(3):263-268. PubMed ID: 32128742 [TBL] [Abstract][Full Text] [Related]
16. Advances in Treatment of Spinal Muscular Atrophy - New Phenotypes, New Challenges, New Implications for Care. Schorling DC; Pechmann A; Kirschner J J Neuromuscul Dis; 2020; 7(1):1-13. PubMed ID: 31707373 [TBL] [Abstract][Full Text] [Related]
17. Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape. Wood MJA; Talbot K; Bowerman M Hum Mol Genet; 2017 Oct; 26(R2):R151-R159. PubMed ID: 28977438 [TBL] [Abstract][Full Text] [Related]